MannKind Corp. buy BiotechBee
Start price
08.09.24
/
60%
€5.49
Target price
28.02.27
€7.00
Performance (%)
17.70%
End price
14.12.24
€6.46
Summary
This prediction ended on 14.12.24 with a price of €6.46. The prediction had a final performance of 17.70%. BiotechBee has 60% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| MannKind Corp. | -4.151% | -4.151% | -43.212% |
| iShares Core DAX® | -1.741% | 5.979% | 8.977% |
| iShares Nasdaq 100 | 2.815% | 11.827% | 38.406% |
| iShares Nikkei 225® | -0.109% | 11.692% | 46.680% |
| iShares S&P 500 | 0.966% | 7.616% | 28.141% |
According to BiotechBee what are the pros and cons of MannKind Corp. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread MannKind Corp. diskutieren
Buy mit Kursziel 7,0
In the thread Trading MannKind Corp.
Buy beendet

